The therapeutic strategy focused on optimizing the natural, intermittent secretion pattern of Growth Hormone (GH) from the anterior pituitary gland, which is characterized by distinct, nocturnal secretory bursts. Effective management aims to enhance the amplitude and frequency of these pulses, rather than maintaining a constant high level, to maximize the anabolic and metabolic benefits of GH. This pulsatile rhythm is essential for tissue repair and body composition maintenance.
Origin
This concept is a cornerstone of clinical endocrinology, derived from the observation that GH is secreted in a highly rhythmic, pulsatile manner. The rhythm is largely controlled by the opposing actions of Growth Hormone-Releasing Hormone (GHRH) and somatostatin. The clinical challenge lies in mimicking this natural rhythm to avoid receptor desensitization.
Mechanism
Management often involves using Growth Hormone Secretagogues (GHSs) or GHRH analogs, which stimulate the pituitary to release its endogenous GH stores in a more physiological, pulsatile pattern, particularly during deep sleep. This mechanism avoids the continuous, non-physiologic stimulation associated with exogenous GH administration. By preserving receptor sensitivity, it optimizes the downstream production of Insulin-like Growth Factor 1 (IGF-1).
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.